当前位置: 首页 >> 检索结果
共有 360 条符合本次的查询结果, 用时 7.6235023 秒

141. Durometry in SSc: The hard facts. A systematic literature review and additional pilot study.

作者: Amber Vanhaecke.;Sven Verschuere.;Veronica Vilela.;Lise Heeman.;Maurizio Cutolo.;Vanessa Smith.
来源: Rheumatology (Oxford). 2021年60卷5期2099-2108页
To investigate the reliability of durometry in systemic sclerosis (SSc), by means of a systematic review and additional pilot study.

142. Rituximab for eosinophilic granulomatosis with polyangiitis: a systematic review of observational studies.

作者: Vincenzo G Menditto.;Giulia Rossetti.;Diletta Olivari.;Alessia Angeletti.;Marco Rocchi.;Armando Gabrielli.;Giovanni Pomponio.
来源: Rheumatology (Oxford). 2021年60卷4期1640-1650页
To analyse the available evidence about the use of rituximab (RTX) and other biologic agents in eosinophilic granulomatosis with polyangiitis (EGPA) patients and to provide useful findings to inform the design of future, reliable clinical trials.

143. Depression and depressive symptoms in patients with polymyalgia rheumatica: discussion points, grey areas and unmet needs emerging from a systematic review of published literature.

作者: Ciro Manzo.;Ayar Nizama-Via.;Marcin Milchert.;Marco Isetta.;Alberto Castagna.;Maria Natale.;Jordi Serra-Mestres.
来源: Reumatologia. 2020年58卷6期381-389页
In 1979, Bird et al. proposed depression as a diagnostic criterion for polymyalgia rheumatica (PMR). More recently, the significance of depression in PMR patients has been re-proposed, , and some researchers have suggested that PMR may increase the risk of depression. The aim of our article is to evaluate the relationship between PMR and depression.

144. The oral and gut microbiome in rheumatoid arthritis patients: a systematic review.

作者: Xiu-Jie Chu.;Nv-Wei Cao.;Hao-Yue Zhou.;Xiang Meng.;Biao Guo.;Hai-Yan Zhang.;Bao-Zhu Li.
来源: Rheumatology (Oxford). 2021年60卷3期1054-1066页
Recently, researchers have proposed a possible relationship between RA and the microbiome of the oral cavity and gut. However, this relation has not been systematically established. Herein, we conducted a comprehensive review of the pertinent literature to describe this possible association.

145. Efficacy and safety of multiple intra-articular corticosteroid injections for osteoarthritis-a systematic review and meta-analysis of randomized controlled trials and observational studies.

作者: Shazeen Ayub.;Jaspreet Kaur.;Michelle Hui.;Shima Espahbodi.;Michelle Hall.;Michael Doherty.;Weiya Zhang.
来源: Rheumatology (Oxford). 2021年60卷4期1629-1639页
To investigate the efficacy and safety of multiple intra-articular corticosteroid (IACS) injections for the treatment of OA.

146. Diagnostic delay in axial spondyloarthritis: a systematic review and meta-analysis.

作者: Sizheng Steven Zhao.;Bradley Pittam.;Nicholas L Harrison.;Ashar E Ahmed.;Nicola J Goodson.;David M Hughes.
来源: Rheumatology (Oxford). 2021年60卷4期1620-1628页
Delay to diagnosis in axial SpA (axSpA) is longer than in many other rheumatic diseases. Prolonged delay is associate with poorer outcomes, including functional impairment and quality of life. Our aims were to describe global variation in delay to diagnosis, factors associated with delay, and delay compared with PsA.

147. Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review.

作者: Martina Orlandi.;Nicholas Landini.;Cosimo Bruni.;Gianluca Sambataro.;Cosimo Nardi.;Elena Bargagli.;Sara Tomassetti.;Mariaelena Occhipinti.;Silvia Bellando Randone.;Serena Guiducci.;Carlo Vancheri.;Stefano Colagrande.;Marco Matucci-Cerinic.
来源: Rheumatology (Oxford). 2020年59卷12期3645-3656页
Pleuroparenchymal fibroelastosis (PPFE) is characterized by predominantly upper lobe pleural and subjacent parenchymal fibrosis; PPFE features were described in patients with rheumatic autoimmune diseases (RAID). A systematic literature review was performed to investigate the prevalence, prognosis and potential association of PPFE with previous immunosuppression in RAID.

148. A systematic review of CXCL13 as a biomarker of disease and treatment response in rheumatoid arthritis.

作者: Katie Bechman.;Anthony Dalrymple.;Charles Southey-Bassols.;Andrew P Cope.;James B Galloway.
来源: BMC Rheumatol. 2020年4卷1期70页
The B cell chemoattractant CXCL13 is a promising biomarker in rheumatoid arthritis (RA), with a plausible role in supporting diagnosis, monitoring disease activity and as a prognostic value. It is a key chemokine driving the formation of lymphoid follicles within the inflamed synovium. The objective of this systematic review was to evaluate the role of CXCL13 as a viable biomarker in RA.

149. Socioeconomic status and occurrence of chronic pain: a meta-analysis.

作者: Jesús Prego-Domínguez.;Zahra Khazaeipour.;Narmeen Mallah.;Bahi Takkouche.
来源: Rheumatology (Oxford). 2021年60卷3期1091-1105页
To examine the association between socioeconomic status (SES) and the occurrence of chronic pain, defined as pain that persists or recurs for >3 months.

150. Prognostic factors for finger interphalangeal joint osteoarthritis: a systematic review.

作者: Karishma Shah.;He Cai.;Jennifer C E Lane.;Gary S Collins.;Nigel K Arden.;Dominic Furniss.;Stephanie R Filbay.
来源: Rheumatology (Oxford). 2021年60卷3期1080-1090页
Radiographic hand OA affects one in five adults. Symptomatic hand OA can result in functional impairment, pain and reduced quality of life. A prevalent form of hand OA is IP joint OA, however prognostic factors for IP joint OA remain poorly understood. This systematic review aimed to identify prognostic factors for IP joint OA, and to summarize the diagnostic criteria for IP joint OA in prognostic studies.

151. Changing evidence over time: updated meta-analysis regarding anti-TNF efficacy in childhood chronic uveitis.

作者: Ilaria Maccora.;Eleonora Fusco.;Edoardo Marrani.;Athimalaipet V Ramanan.;Gabriele Simonini.
来源: Rheumatology (Oxford). 2021年60卷2期568-587页
To summarize evidence regarding efficacy of anti-TNFα in childhood chronic uveitis, refractory to common DMARDs.

152. Colchicine treatment increases the risk for fetal chromosomal aberrations-an observational study and systematic literature review.

作者: Amihood Singer.;Julia Grinshpun-Cohen.;Lena Sagi-Dain.
来源: Rheumatology (Oxford). 2021年60卷5期2342-2347页
To examine the risk for chromosomal aberrations in fetuses of colchicine-treated patients in a large cohort, and to perform a systematic literature review on the subject.

153. Rituximab in the treatment of systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis.

作者: Rudra P Goswami.;Animesh Ray.;Moumita Chatterjee.;Arindam Mukherjee.;Geetabali Sircar.;Parasar Ghosh.
来源: Rheumatology (Oxford). 2021年60卷2期557-567页
To assess the effect of rituximab (RTX) on the lung function parameters in SSc interstitial lung disease (SSc-ILD) patients.

154. Cannabis use assessment and its impact on pain in rheumatologic diseases: a systematic review and meta-analysis.

作者: M Guillouard.;N Authier.;B Pereira.;M Soubrier.;S Mathieu.
来源: Rheumatology (Oxford). 2021年60卷2期549-556页
Despite classic analgesic or effective treatments in rheumatic diseases, such as synthetic DMARDs in RA, patients remain in pain and often turn to non-prescribed pharmacological alternatives, such as cannabis self-therapeutic use. However, this medical use of cannabis has not been thoroughly studied.

155. Response to placebo in non-renal, non-neuropsychiatric systemic lupus erythematosus: a systematic review and pooled analysis.

作者: Konstantinos Tselios.;Laura Wakani.;Dafna D Gladman.;Jiandong Su.;Murray B Urowitz.
来源: Rheumatology (Oxford). 2021年60卷1期73-80页
Most randomized controlled trials (RCTs) in SLE have failed to reach their respective end points, with the rates of response to placebo (plus standard-of-care treatment) being unexpectedly high. The aim of this systematic review was to quantify the response to placebo in non-renal, non-neuropsychiatric lupus.

156. Systematic review and meta-analysis of epidemiological studies on the association of occupational exposure to free crystalline silica and systemic lupus erythematosus.

作者: Alberto Morotti.;Irena Sollaku.;Simona Catalani.;Franco Franceschini.;Ilaria Cavazzana.;Micaela Fredi.;Emma Sala.;Giuseppe De Palma.
来源: Rheumatology (Oxford). 2021年60卷1期81-91页
Some evidence suggests that exposure to free crystalline silica may contribute to the risk of developing SLE. A systematic search was carried out for all published epidemiological studies concerning this association. A meta-analysis was conducted on relevant studies.

157. Rheumatic manifestations of COVID-19: a systematic review and meta-analysis.

作者: Jacopo Ciaffi.;Riccardo Meliconi.;Piero Ruscitti.;Onorina Berardicurti.;Roberto Giacomelli.;Francesco Ursini.
来源: BMC Rheumatol. 2020年4卷65页
Different proportions of musculoskeletal or autoimmune manifestations associated with COVID-19 have been reported in literature. We performed a systematic review and meta-analysis with the aim of assessing the prevalence of rheumatic manifestations in patients affected by COVID-19, as initial symptom or during disease course.

158. The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis.

作者: José María Pego-Reigosa.;Lindsay Nicholson.;Nick Pooley.;Sue Langham.;Nina Embleton.;Zoe Marjenberg.;Volkan Barut.;Barnabas Desta.;Xia Wang.;Julia Langham.;Edward R Hammond.
来源: Rheumatology (Oxford). 2021年60卷1期60-72页
We conducted a systematic review and meta-analysis to determine the magnitude of infection risk in patients with SLE and evaluate the effect of general and SLE-related factors on infection risk.

159. Which disease activity outcome measure discriminates best in axial spondyloarthritis? A systematic literature review and meta-analysis.

作者: Augusta Ortolan.;Victoria Navarro-Compán.;Alexandre Sepriano.;Robert B M Landewé.;Désirée van der Heijde.;Sofia Ramiro.
来源: Rheumatology (Oxford). 2020年59卷12期3990-3992页

160. Takotsubo syndrome and rheumatic diseases-a critical systematic review.

作者: Weiqin Lin.;Sen Hee Tay.;Anselm Mak.
来源: Rheumatology (Oxford). 2021年60卷1期11-22页
Since its description in 1990, Takotsubo syndrome (TTS), an acute cardiac condition triggered by physical or emotional stress, has been believed to be related to catecholamine surge from overwhelming sympathetic activity. While symptomatology, biochemical features, ECG and echocardiogram alterations are largely indistinguishable from acute coronary syndrome, the absence of culprit coronary lesions often necessitates further investigations, uncovering underlying inflammatory processes. Mechanistically, animal models of TTS reveal early neutrophil infiltration followed by staged ingression of two subtypes of macrophages (M1, M2) mediating initial acute inflammatory changes (M1), followed by switching to anti-inflammatory signals (M2) that enhance myocardial tissue recovery. Here, we begin with a description of two TTS patients with primary Sjögren's syndrome and Takayasu's arteritis, followed by a systematic literature review that summarizes the demographic and clinical features of TTS patients with rheumatological conditions. Potential impact of disease manifestations and treatment of rheumatological conditions on TTS are critically discussed.
共有 360 条符合本次的查询结果, 用时 7.6235023 秒